Peripheral Artery Disease Market Demand and Growth Analysis 2025-2033

The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate

IMARC Group’s report titled “Peripheral Artery Disease Market Report by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033”. The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033.

Factors Affecting the Growth of the Peripheral Artery Disease Industry:

• Aging Population:

PAD is common in older adults. As the global population ages, there are more people at risk for PAD. This increases the number of cases. As a result, the demand for diagnosis and treatment increases. Older adults often have risk factors for PAD. These include high blood pressure, high cholesterol, diabetes, and a history of smoking. Over time, these factors add up, resulting in more cases of PAD in this age group.

• Rising Incidence of Diabetes and Hypertension:

Diabetes and hypertension are key risk factors for PAD. Their global rise is directly linked to more PAD cases. Patients with these conditions face a higher PAD risk due to related vascular issues. Both diseases harm blood vessels, leading to atherosclerosis. This is a plaque buildup in arteries. Such vascular damage is a main cause of PAD.

• Lifestyle Changes:

Today, many people lead sedentary lifestyles. They often sit for long hours at work and engage in little physical activity. This lack of movement increases the risk of Peripheral Artery Disease (PAD) by causing poor circulation and obesity, among other health issues. Diets high in saturated fats, trans fats, cholesterol, and sodium also play a significant role. These unhealthy diets contribute to atherosclerosis, a condition where arteries narrow and harden. Atherosclerosis is a major cause of PAD. Thus, the widespread consumption of unhealthy foods drives up the rates of this disease.

Grab a sample PDF of this report: https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample

Leading Companies Operating in the Peripheral Artery Disease Industry:

• Abbott Laboratories

• AngioDynamics

• B. Braun Melsungen AG

• Becton Dickinson and Company

• Biotronik SE & Co. KG

• Boston Scientific Corporation

• Cardinal Health Inc.

• Cook Medical LLC

• Koninklijke Philips N.V.

• Medtronic plc

• Terumo Corporation

Peripheral Artery Disease Market Report Segmentation:

By Type:

• Peripheral Angioplasty Balloons

• Peripheral Stents

• Peripheral Catheters

• Inferior Vena Cava (IVC) Filters

• Plaque Modification Devices

• Hemodynamic Flow Alteration Devices

• Peripheral Accessories

Peripheral stents represent the largest segment. Peripheral stents are widely used for treating arterial blockages in PAD patients, offering effective vascular support and durability compared to other treatment options.

By End User:

• Hospitals

• Specialty Clinics

• Others

Based on the end-user, the market has been divided into hospitals, specialty clinics, and others.

Regional Insights:

• North America (the United States and Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)

• Europe (Germany, France, the United Kingdom, Italy, Spain, and others)

• Latin America (Brazil, Mexico, and others); the Middle East; and Africa.

North America enjoys the leading position due to high healthcare expenditure, advanced medical infrastructure, extensive adoption of innovative PAD treatments, and a growing elderly population prone to PAD-related conditions.

Global Peripheral Artery Disease Market Trends:

Ongoing innovations in medical devices, such as drug-eluting stents and minimally invasive procedures, are improving treatment efficacy and patient outcomes in PAD management. The growing elderly population globally is contributing to high prevalence rates of PAD, driving the demand for diagnostics and therapeutic solutions. There is a growing emphasis on early detection and prevention strategies for PAD, including lifestyle interventions and screening programs, aimed at reducing disease progression. Developing regions are witnessing increased awareness, improved healthcare infrastructure, and rising disposable incomes, leading to greater access to PAD treatments and expanding market opportunities.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: [e-mail] Tel No:(D) [phone] United States: [phone]